Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

Yang, Kunyu, Sheng, Yuhan, Huang, Chaolin, Jin, Yang, Xiong, Nian, Jiang, Ke, Lu, Hongda, Liu, Jing +16 more·2020·The Lancet Oncology
DOI 10.1016/s1470-2045(20)30310-7

Cited by (579)

Items 301–400 of 579

  1. Effect of COVID-19 on the delivery of care for thoracic surgical patients
    Dao M. Nguyen, Karishma Kodia, Joanne B. Szewczyk, Ahmed Alnajar, Joy A. Stephens-McDonnough, Nestor R. Villamizar · 2022 · JTCVS Open
  2. Gut-Lung Microbiota Characterization in Patients with Non-Small Cell Lung Carcinoma and COVID-19 Coinfection
    Bahareh Vakili, Parisa Shoaei, Kiana Shahzamani, Seyed Davar Siadat, Hasan Shojaei, Zahra Esfandiari, Elahe Nasri, Shiva Shabani, Ali Zamani Moghadam, Behrooz Ataei · 2024 · Archives of Iranian Medicine
  3. Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges
    Idris Nasir Abdullahi, Anthony Uchenna Emeribe, Hafeez Aderinsayo Adekola, Sharafudeen Dahiru Abubakar, Amos Dangana, Halima Ali Shuwa, Sunday Theophilus Nwoba, Jelili Olaide Mustapha, Muyideen Haruna, Adepeju Kafayat Olowookere et al. · 2020 · Human Vaccines & Immunotherapeutics
  4. Radiotherapy and COVID-19 pandemic - a review of the current recommendations
    Aleksandar Stepanović, Marina Nikitović · 2020 · Srpski arhiv za celokupno lekarstvo
  5. Weathering the storm: COVID-19 infection in patients with hematological malignancies
    Lin-Qin Wang, Elaine Tan Su Yin, Guoqing Wei, Yongxian Hu, Arnon Nagler, He Huang · 2020 · Journal of Zhejiang University SCIENCE B
  6. The effect of COVID-19 pandemic on daily oncology clinical practice
    Giovanni Codacci-Pisanelli, Jacopo Giuliani, Andrea Vincent Bonetti · 2021 · Critical Reviews in Oncology/Hematology
  7. Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials
    Shervin Tabrizi, Lorenzo Trippa, Daniel N. Cagney, Ayal Aaron Aizer, Shyam Kumar Tanguturi, Steffen Ventz, Geoffrey G. Fell, Jennifer Ruth Bellon, Harvey J. Mamon, Paul Linh Nguyen et al. · 2021 · JAMA Network Open
  8. SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy
    Lova Sun, Sanjna Surya, Noah G. Goodman, Anh N. Le, Gregory Kelly, Olutosin Owoyemi, Heena Desai, Cathy Zheng, Shannon DeLuca, Madeline L. Good et al. · 2021 · JCO Oncology Practice
  9. Prognostic Accuracy of Cardiovascular Disease Biomarkers in Patients with COVID-19: A Diagnostic Test Accuracy Meta‐analysis
    Atefeh Nasir Kansestani, Mohammad Erfan Zare, Jun Zhang · 2021 · The Journal of Tehran University Heart Center
  10. Chemotherapy resumption in breast cancer patient after COVID-19
    Julian Horiguchi, Ayako Nakashoji, Naoki Kawahara, Akira Matsui, Takayuki Kinoshita · 2021 · Surgical Case Reports
  11. Could Immunonutrition Help in the Fight against COVID-19 in Cancer Patient?
    Gang Tang, Linyu Zhang, Wang Huang, Zhengqiang Wei · 2021 · Nutrition and Cancer
  12. Telehealth and Telemedicine in response to selected critical coronavirus: A systematic review
    2021 · Iranian Red Crescent Medical Journal
  13. Outcomes and Risk Factors of Patients With COVID-19 and Cancer (ONCORONA): Findings from The Philippine CORONA Study
    Adrian Isidoro Espiritu, Ramon B. Larrazabal, Marie Charmaine C. Sy, Emilio Q. Villanueva, Veeda Michelle M. Anlacan, Roland Dominic G. Jamora · 2022 · Frontiers in Oncology
  14. General Oncology Care in Tunisia
    Nesrine Mejri, Haifa Rachdi, Lotfi Kochbati, Hamouda Boussen · 2022 · Springer eBooks
  15. COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivors
    Adana A. M. Llanos, Angela J. Fong, Nabarun Ghosh, Katie A. Devine, Denalee M. O’Malley, Lisa E. Paddock, Elisa Victoria Bandera, Shawna V. Hudson, Andrew M. Evens, Sharon L. Manne · 2022 · Journal of Cancer Survivorship
  16. Null-values imputation using different modification random forest algorithm
    Maad Mohsin Mijwil, Alaa Wagih Abdulqader, Sura Mazin Ali, Ahmed T. Sadiq · 2022 · IAES International Journal of Artificial Intelligence
  17. RETRACTED: SARS-CoV-2 impact on ACE2 expression in NSCLC: mRNA and protein insights COVID-19 associated (ACE2) expression in non-small cell lung cancer (NSCLC)
    Dalia Mostafa Domiaty, Tahani Mohamed Ibrahim Al-Hazani, Eman Alshehri, Haya Zamil aldajani, Naseem Abdulrahman Fahad Alqassim, Abdullah Mohammed Al-balawi, Fatima Abdullah AlQassim, Manal Abdullah Alduwish, Wedad Saeed Al-Qahtani · 2023 · Heliyon · Retracted
  18. Hospital and post-discharge mortality in COVID-19 patients with a preexisting cancer diagnosis in Iran
    Monireh Sadat Seyyedsalehi, Marveh Rahmati, Reza Ghalehtaki, Azin Nahvijou, Bita Eslami, Zoha Shaka, Seyed Farshad Allameh, Kazem Zendehdel · 2024 · BMC Cancer
  19. Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic
    Gianpiero Fasola, Giacomo Pelizzari, Diego Zara, Giada Targato, Giuseppe Petruzzellis, Alessandro Marco Minisini, Alessandra Bin, Raffaela Donato, Mauro Mansutti, Chiara Comuzzi et al. · 2021 · The Oncologist
  20. Delivery of systemic anti-cancer therapy during the COVID-19 pandemic
    Orla M. Fitzpatrick, Róisín Ní Dhónaill, Anna Linehan, Zac L. Coyne, Maeve Hennessy, Maeve Clarke, Elizabeth McGee, Fiona Barrett, Deborah O’Doherty, C. Matassa et al. · 2021 · Irish Journal of Medical Science (1971 -)
  21. Profiles and outcomes in patients with COVID-19 admitted to wards of a French oncohematological hospital: A clustering approach
    Louise Bondeelle, Sylvie Chevret, S. Cassonnet, Stéphanie Harel, Blandine Denis, Nathalie De Castro, Anne Bergeron, on behalf of The Saint Louis CORE Team Group · 2021 · PLoS ONE
  22. Nutrition in Cancer Patients Positive for COVID-19; Case Series and a Systematic Review of Literature
    Gulsen Saleh, Aliaa Ahmed, Omneya Hassanain, Aya Emad, Samer Essameldin, Marianne Ragai, Yasmin Saad · 2021 · Nutrition and Cancer
  23. Trends in COVID-19 cases and clinical management in Veterans Health Administration medical facilities: A national cohort study
    Maya Aboumrad, Brian R. Shiner, Natalie B. V. Riblet, Hugh Huizenga, Nabin Neupane, Yinong Young‐Xu · 2021 · PLoS ONE
  24. Clinical characteristics and outcomes of cancer patients and their hospital course during the COVID-19 pandemic in a developing country
    Muhammad Sohaib Asghar, Farah Yasmin, Maryam Salma Babar, Muhammad Daim Bin Zafar, Syed Muhammad Ismail Shah, Muhammad Junaid Tahir · 2022 · Annals of Medicine and Surgery
  25. Predictions of cancer mortality in Europe in 2021: room for hope in the shadow of COVID-19?
    Jose Maria Martin-Moreno, Suszy Lessof · 2021 · Annals of Oncology
  26. Machine learning methods and approaches for predicting Covid19
    Marwah Nihad, Fawzya Ramadan Sayed, Sura I. Mohammed Ali · 2023 · AIP conference proceedings
  27. Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis
    M. P. Sullivan, Xiudong Jennifer Lei, Sharon Hermes Giordano, Mariana Chávez‐MacGregor · 2024 · Breast Cancer Research and Treatment
  28. MS4A1-PTGS2 axis induces taurine metabolic reprogramming to exacerbate abdominal aortic aneurysm progression
    Xuejun Sun, Chaoxiang Du, Ye Chen, Zhibin Cai, Liangwan Chen · 2024 · International Journal of Medical Sciences
  29. SARS‐CoV‐2‐related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan‐cancers
    Xue‐Ping Li, Xin Huang, Yan‐Mei Qin, Guo‐Yan Wu, Chengcai Liang, Yu‐Jun Dai, Weina Zhang · 2021 · Clinical and Translational Medicine
  30. Survival outcomes of alternate dosing schedule of pemetrexed as maintenance therapy in NSCLC: Single institution experience
    Mark G. Faber, Chong Wang, Sruthi Kommi Reddy, Alison K Meagher, Amy Early, Hongbin Chen, Grace Kho Dy · 2022 · Lung Cancer
  31. Fatores associados ao óbito entre pacientes com câncer internados por COVID-19 em Mato Grosso, Brasil
    Ana Paula Muraro, Lígia Regina de Oliveira, Amanda Cristina de Souza Andrade, Ana Cláudia Pereira Terças‐Trettel, Lenir Vaz Guimarães, Bárbara da Silva Nalin de Souza · 2022 · Revista Brasileira de Epidemiologia
  32. Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison retrospective study between cancer and kidney transplant patients
    Minoosh Moghimi, Manijeh Jozpanahi, Kasra Khodadadi, Seyede Pegah Saeed, Seyede Vanoushe Azimi Pirsaraei, Nooshin Jalili · 2022 · European Journal of Translational Myology
  33. A novel intubation prediction model for patients hospitalized with COVID-19: the OTO-COVID-19 scoring model
    Muhammed Okuyucu, Taner Tunç, Yusuf Taha Güllü, İlkay Bozkurt, Murat Esen, Onur Öztürk · 2022 · Current Medical Research and Opinion
  34. Anticancer Therapy and Mortality of Adult Patients with Hematologic Malignancy and COVID-19: A Systematic Review and Meta-Analysis
    Wen-Li Lin, Thi‐Hoang‐Yen Nguyen, Li‐Min Wu, Wen-Tsung Huang, Shih‐Bin Su · 2023 · Life
  35. [Effect of Different Antitumor Regimens on Incidence and Severity of Corona Virus Disease 2019 Pneumonia in Lung Cancer Patients: A Single-center Retrospective Study].
    Wanjun Lu, Jiawen Lv, Qin Lin Wang, Yanwen Yao, Dong Wang, Jiayan Chen, Guannan Wu, Xiaoling Gu, Huijuan Li, Yajuan Chen et al. · 2023 · PubMed Central
  36. The impact of COVID ‐19 on mortality, length of stay, and cost of care among patients with gastrointestinal malignancies: A propensity score‐matched analysis
    Mark Bilinyi Ulanja, Bryce David Beutler, Kwabena Oppong Asafo-Agyei, Samuel Governor, Samuel Edusa, Daniel Antwi‐Amoabeng, Reginald N. Ulanja, Grace B. Nteim, Millicent Amankwah, Vijay Neelam et al. · 2023 · Cancer Medicine
  37. Post-traumatic stress disorder symptoms and quality of life among older patients with cancer during the COVID-19 pandemic.
    F. Cherifi, F. Gernier, Fabrice Jardin, Sophie Lefèvre-Arbogast, E. Bastien, J. Lequesne, O. Rigal, F. Quilan, B. Clarisse, J. Grellard et al. · 2023 · Journal of Geriatric Oncology
  38. New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer
    Vittoria Rago, Sabrina Bossio, Danilo Lofaro, Anna Perri, Silvia Di Agostino · 2023 · Life
  39. Using machine learning algorithms based on patient admission laboratory parameters to predict adverse outcomes in COVID-19 patients
    Yuchen Fu, Xuejing Xu, Juan Du, Taihong Huang, Jiping Shi, Guanghao Song, Qing Gu, Han Xin Shen, Sen Wang · 2024 · Heliyon
  40. ACE2: the node connecting the lung cancer and COVID-19
    Liao Yan · 2024 · American Journal of Cancer Research
  41. Clinical characteristics and prognostic factors of COVID-19 infection among cancer patients during the December 2022 – February 2023 Omicron variant outbreak
    Lili Liu, Yu-Wei Liao, Xiaohua Yu, Ling Rong, Bi-Gui Chen, Gang Chen, Guang-Kuan Zeng, Li‐Ye Yang · 2024 · Frontiers in Medicine
  42. Risk of COVID-19 infection in patients with NSCLC receiving EGFR-TKI targeted therapy during the first wave in China
    Peng Huang, Ling-Ming Liao, Jiali Zhao, Chen Huan Luo, Yan-Ling Yi, Yu Chen, Long Huang · 2024 · Journal of International Medical Research
  43. Changes in Pancreatic Cancer Management and Surgical Treatment During the COVID-19 Pandemic
    Aida Puia, Cătălin Vlăduț Ionuț Feier, Vasile Gaborean, Raluca Bodea, Florin Graur, Florin Vasile Zaharie, Nadim Al Hajjar, Ion Cosmin Puia · 2024 · Medicina
  44. A narrative review of the pathophysiology of COVID ‐19 infection among cancer patients: Current evidence and research perspectives
    Vinod K. Ramani, Radheshyam Naik · 2021 · Health Science Reports
  45. Risk factors and indicators for COVID-19 severity: Clinical severe cases and their implications to prevention and treatment
    Kexin Tang · 2020 · International Conference on Public Health and Data Science (ICPHDS)
  46. Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic
    Chris Labaki, Solange Peters, Toni K. Choueiri · 2021 · Cancer Discovery
  47. Safety, Efficacy and Acceptability of SARS-CoV-2 Vaccines in Patients With Cancer
    Roy Chebel, Chris Labaki, Maria Farhat, Joseph Gergi Kattan · 2021 · Future Virology
  48. Clinical Characteristics, Management, and Outcomes of Cancer Patients With Coronavirus Disease 2019 Admitted to the ICU
    Michael K. M. Dang, Isha Bhatt, Alina O. Dulu, Hao Zhang, Natalie T. Kostelecky, Stephen M. Pastores · 2021 · Critical Care Explorations
  49. Clinical and Laboratory Outcomes of the Solid Cancer Patients Reinfected with SARS-CoV-2
    Oktay Ünsal, Ozan Yazıcı, Nuriye Özdemir, Erdem Çubukçu, Birol Ocak, Aytuğ Üner, Ahmet Özet · 2021 · Future Oncology
  50. Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis
    Zheng Li, Qiang Li, Xiaohu Wang, Sha Li, Wei‐Qiang Chen, Xiaodong Jin, Xinguo Liu, Zhongying Dai, Xiongxiong Liu, Xiaogang Zheng et al. · 2021 · Frontiers in Public Health
  51. Healthcare Disparities and Outcomes of Cancer Patients in a Community Setting from a COVID-19 Epicenter
    Brianna M. Jones, Eric J. Lehrer, Anurag Saraf, Zahra Shafaee, Lucas Resende Salgado, Virginia Wedell Osborn · 2022 · Current Oncology
  52. Evolving management strategies for lymphomas during the COVID-19 pandemic
    Noémie Lang, John G. Kuruvilla · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
  53. COVID-19 Vaccination in Patients with Classic Kaposi’s Sarcoma
    Alice Indini, Athanasia Tourlaki, Francesco Grossi, Donatella Gambini, Lucia Brambilla · 2021 · Vaccines
  54. Association of active immunotherapy with outcomes in cancer patients with COVID-19: a systematic review and meta-analysis
    Chang Qing Cao, Xinyan Gan, Xiaolin Hu, Yonglin Su, Yu Zhang, Xingchen Peng · 2022 · Aging
  55. A novel scoring system in mortality prediction of severe patients with COVID-19
    Anwen Shao, Yunxiang Zhou, Sheng Tu, Jifang Sheng · 2020 · EClinicalMedicine
  56. The challenge and management of nosocomial infection control during the “post-outbreak” period of SARS-CoV-2
    Lixiang Wang, Xinghui Liu, Xiaoyan Tang, Hui Zhang · 2020 · Chinese Science Bulletin (Chinese Version)
  57. COVID-19 and colorectal cancer – signs of a toxic relationship and how to break the cycle: a single institution, tertiary centre experience
    Petar Matošević, Vedrana Biošić, Lucija Brkić, Andrija Matijević, Ozana Miličević, Ines Trkulja, Hrvoje Silovski, Emil Kinda · 2021 · Libri Oncologici Croatian Journal of Oncology
  58. Risk factors for in-hospital mortality in patients with cancer and COVID-19
    Guosen Zhang, Yang An, Lu Zhang, Longxiang Xie, Xiangqian Guo · 2020 · The Lancet Oncology
  59. The burden of COVID-19 death for different cancer types: a large population-based study
    You Mo, Duncan Wei, Xiaozheng Chen, Zengfu Zhang, Wen Huo, Meng Wu, Dawei Chen, Jinming Yu · 2025 · Journal of Global Health
  60. Determinants of SARS-CoV-2 outcomes in patients with cancer vs controls without cancer: a multivariable meta-analysis with genomic imputation
    M. Cheng, J. Morris, S. F. Shah, A. Tolley, J. Chen-Xu, Nihal Sogandji, L. H. Fong, Anushka Irodi, Justine Chan, K. Kamelian et al. · 2025 · EClinicalMedicine
  61. Ninety‐day mortality and clinical outcomes of patients with solid tumours and COVID ‐19 infection during the first pandemic outbreak in Catalonia, Spain: A multicentre retrospective study
    José Carlos Tapia, Javier Gavira, Assumpció López, Laia Llobera, Ona Pallisé, Irene Marsal, Alba Cochs, Oscar J. Ponce, Mariona Riudavets, Ignasi J. Gich et al. · 2021 · International Journal of Cancer
  62. Mortality of COVID-19 pneumonia during anticancer treatment in lung cancer patients
    Daliborka Bursać, Bojan Zarić, Darijo Bokan, Tomi Kovačević, Vladimir Stojšić, Svetlana Petkov, Kosana Mitrovic, Goran M. Stojanović · 2022 · Vojnosanitetski pregled
  63. Infectious spondylodiscitis: When a rare infection is associated with uncommon findings!
    Ons Hamdi, Manel Boudokhane, Zeineb Teyeb, Taieb Jomni, Imene Abdelaali, Syrine Bellakhal, Mohamed Hédi Dougui · 2022 · Revista Colombiana de Reumatología
  64. SARS-CoV-2 Virus in Cancer Patients: A New Unknown in an Unsolved Equation
    M. Martín, Carmen Vallejo, Fernando López‐Campos, Carmen Quereda, Teresa Muñóz, Matilde Sánchez‐Conde, Jose Antonio Dominguez, Cruz Soriano, Mercedes Martín, Cecilia Suárez Carantoña et al. · 2022 · Oncology
  65. Non-Dexamethasone Corticosteroid Therapy’s Effect on COVID-19 Prognosis in Cancer Patients: A Retrospective Study
    Lina Souan, Zienab Al-Khairy, Abdelkader Battah, Maher A. Sughayer · 2023 · Vaccines
  66. Prognostic Factors for Survival or Severity After COVID-19 Infection in Cancer Patients: A Systematic Review and Meta-Analysis
    Eun Jung Lee, Jae Hoon Cho · 2023 · Journal of rhinology
  67. SARS‐CoV‐2 virus associated angiotensin converting enzyme 2 expression modulation in colorectal cancer: Insights from mRNA and protein analysis COVID-19 associated (ACE2) expression in colorectal cancer
    Mashael Alhumaidi Alotaibi, Tahani Mohamed Ibrahim Al-Hazani, Maha A. Alwaili, Areej S. Jalal, Dalal Sulaiman Alshaya, Fatmah Ahmed Safhi, Muna Omer Alamoudi, Saud A. Alarifi, Wedad Saeed Al-Qahtani · 2023 · Microbial Pathogenesis
  68. COVID-19 among lung cancer patients: Data from a real-life prospective French multicentric study
    Oliver Molinier, Julian Pinsolle, A. Bizieux Thaminy, Sebastian C. Schneider, B. Godbert, Laurent Portel, F. Hugues, Charles Dayen, J. Obert, Cécile Dujon et al. · 2024 · Respiratory Medicine and Research
  69. In silico analysis of the key molecules of SARS-CoV-2: ACE2 and TMPRSS2 in head and neck cancer
    Vignesh Mariappan, Aashika Raagavi JeanPierre, P. S. Manoharan, Dhamodharan Ramasamy, Agieshkumar Balakrishna Pillai · 2024 · Human Gene
  70. Updated COVID-19 Pharmacotherapy in Different Diseases Such as Cancer
    Zahra Tolou–Ghamari · 2024 · Coronaviruses
  71. The global effects of digestive system cancers worldwide on the COVID-19 pandemic by negative binomial (mixed) regression models
    Neslihan İyit · 2024 · Journal of Radiation Research and Applied Sciences
  72. Surgical Challenges During the COVID-19 Crisis: A Comparative Study of Inguinal Hernia Treatment in Romania
    Cătălin Vlăduț Ionuț Feier, Călin Muntean, Vasile Gaborean, Razvan Constantin Vonica, Alaviana Monique Faur, Marius-Sorin Murariu, Sorin Olariu · 2024 · Medicina
  73. TIM3 in COVID-19; A potential hallmark?
    Mohammad Reza Zamani, Pavel Šácha · 2024 · Heliyon
  74. Incidence, pathophysiology, risk factors, histopathology, and outcomes of COVID-19-induced acute kidney injury: A narrative review
    Abdelhamid Hachimi, Bilal El‐Mansoury, Mohamed Merzouki · 2025 · Microbial Pathogenesis
  75. Antitumor proteinkinase inhibitor imatinib may be regarded as a potential correcting agent for COVID-19 associated pulmonary fibrosis
    I. N. Mikhaylova, N. M. Treshalina, Irina Zh. Shubina, Манина Ирина Владимировна, M. V. Kiselevsky, Alexander N. Lukashev · 2021 · Advances in molecular oncology
  76. SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria
    Julia Maria Berger, P. Wohlfarth, Oliver Königsbrügge, Hanna A. Knaus, Edit Anna Porpaczy, Hannes Kaufmann, Johanna Schreiber, Tatevik Mrva-Ghukasyan, Thomas L. Winder, Luciano Severgnini et al. · 2022 · Wiener klinische Wochenschrift
  77. Risk Factors for Mortality Among COVID-19 Patients in Asia: A Literature Review
    Hoirun Nisa, Adi Setya Frida Utami, Anissa Dwi Oktaviani · 2022 · Jurnal Ilmu dan Teknologi Kesehatan
  78. Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors
    Guoqun Wang, Lanlan Pan, Jianyi Zhao, Jie Tang, Yueyu Fang, Hui‐Chuan Sun, Poshita Kumari Seesaha, Wensen Chen, Xiaofeng Chen · 2022 · Medicine
  79. Is cancer significant comorbid condition in COVID 19 infected patients? -A retrospective analysis experienced in a tertiary care center in Eastern India
    Kalyan Kusum Mukherjee, Aniruddha Dam, Deepa Chakrabarti, Debasish Jatu, Saubhik Sengupta, Rita Dutta, Suparna Majumdar, Shyam Sundar Mandal, Biswarup Basu, Pratiti Bhattacharjee et al. · 2022 · Annals of Medicine and Surgery
  80. Use of Umbilical Cord Mesencymal Stem Cells in the Treatment of Severe COVID-19 Pneumonia
    Michelle Joy De Vera · 2021 · Journal of Embryology & Stem Cell Research
  81. Predictors of adverse COVID-19 outcomes in patients with oncohematological diseases
    M. Shapetska, Igor Iskrov, I. Yu. Lendina, И. О. Стома · 2021 · Health and Ecology Issues
  82. Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report
    Stanisław Łącki-Zynzeling, Kinga Wyżgolik, Michał Nicze, Sylwia Georgiew-Nadziakiewicz, Jerzy Tadeusz Chudek, Kamil Wdowiak · 2021 · World Journal of Clinical Cases
  83. Perfil sociodemográfico e clínico de pacientes com câncer no contexto da pandemia da COVID-19 em um Hospital Universitário do Nordeste: estudo transversal
    José Fontes Júnior, Érika Ramos Silva, Lucas Aragão da Hora Almeida, Caroline Nunes dos Santos, Júlia Júlia Lorena Santos de Souza, David Jacinto Bezerra, Carlos José Oliveira de Matos, Patrícia Silva Tofani · 2021 · Research Society and Development
  84. Clinical characteristics of lung cancer patients with COVID-19: Retrospective case series
    Yusuf Kahya, Güle Çınar, Buse Mine Konuk Balcı, Cabir Yüksel, Kemal Osman Memikoğlu · 2021 · Tuberkuloz ve Toraks
  85. Evaluating potential delays and outcomes of patients undergoing surgical resection for locally advanced and recurrent colorectal cancer during a pandemic
    MA Javed, A Kohler, Jim P. Tiernan, Aaron J. Quyn, Peter Michael Sagar · 2022 · Annals of The Royal College of Surgeons of England
  86. Factors associated with death among cancer patients hospitalized for COVID-19 in Mato Grosso, Brazil
    Ana Paula Muraro, Lígia Regina de Oliveira, Amanda Cristina de Souza Andrade, Ana Cláudia Pereira Terças‐Trettel, Lenir Vaz Guimarães, Bárbara da Silva Nalin de Souza · 2022 · Revista Brasileira de Epidemiologia
  87. Features of the State of Cellular Immunity in Patients with Hematology Diseases who have Undergone COVID-19
    Е.В. Игнатьева, А.В. Зинченко, С. П. Казаков, О. А. Рукавицын · 2022 · Гематология Трансфузиология Восточная Европа
  88. COVID-19 infection in patients with haematological disease - A tertiary centre experience from north India
    Mukul Aggarwal, Mirza Saleem Amjad, Akash Khandelwal, Pradeep Kumar, Rishi Dhawan, Jasmita Dass, Ganesh Kumar Viswanathan, Punit Khanna, Akhil Kant Singh, Kapil Dev Soni et al. · 2022 · International Journal of Microbiology Research
  89. Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from India
    Akash Kumar, Saphalta Baghmar, Prashant Mehta, Priya Tiwari, Lalit Kumar, Sameer Bakhshi, Amit K. Agarwal, Ishaan Gupta, Anjan Trikha, Sushma Bhatnagar et al. · 2022 · International Journal of Microbiology Research
  90. “Predictors of in-hospital mortality in adult cancer patients with COVID-19 infection presenting to the emergency department: A retrospective study”
    Imad El Majzoub, Nour Kalot, Malak Khalifeh, Natalie Estelly, Tharwat El Zahran · 2023 · PLoS ONE
  91. COVID-19 Cluster in the Hematology/Respirology Ward of a University Hospital during the Seventh Wave of the SARS-CoV-2 Pandemic in Japan: A Descriptive Study
    Fumiya Ogasawara, Shohei Yoshida, Mayuka Yamane, Kazufumi Takamatsu, Yu Arakawa, Yoshie Nishida, Megumi Komatsu, Akihito Yokoyama, Yuka Yamagishi, Kensuke Kojima · 2023 · Internal Medicine
  92. Learning from cancer to address COVID-19
    Edith Oláh · 2023 · Biologia Futura
  93. Recent antitumor therapy does not increase Omicron COVID-19 severity in cancer patients: a two-center retrospective study in China
    Ying Liu, Wenyao Zhu, Zhiwu Wang, Jiarui Yu, Liang Dong, Chunyang Li, Weimin Wang, Fuhui Zhang, Shuanghui Ding, Lu Sun et al. · 2023 · Frontiers in Oncology
  94. Outcomes of COVID ‐19 in patients with lymphomas participating in registered clinical trials: A real‐world study from China in the Omicron outbreak era
    Peng Sun, Hang Yang, Baitian Zhao, Yu Wang, Man Nie, Kangming Huang, Zhiming Li · 2023 · Cancer Medicine
  95. Clinical, inflammatory, and immune differences between COVID-19 patients with and without cancer
    Zhongyang Yu, Peipei Wang, Bailin Chen, Zihao Zhang, Jun Jiang, Yulong Zhuang · 2020 · Medicine
  96. Coronavirus Disease (COVID-19) Testing in Asymptomatic Patients Planned for Day Care Systemic Therapy: A Tertiary Cancer Center Experience
    Jerin Ovett, Manikandan Dhanushkodi, Venkatraman Srinivasan Radhakrishnan, Nikita Mehra, Jayachandran Perumal Kalaiyarasi, Gangothri Selvarajan, Arun Kumar Rajan, Parathan Karunakaran, Sivasree Kesana, Tenali Gnana Sagar · 2021 · Indian Journal of Medical and Paediatric Oncology
  97. HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY
    Stefano Botti, Nicola Serra, Fausto Castagnetti, Sabina Chiaretti, Nicola Mordini, Gianpaolo Gargiulo, Laura Orlando · 2020 · Mediterranean Journal of Hematology and Infectious Diseases
  98. Risk factors for in-hospital mortality in patients with cancer and COVID-19
    Kaibo Guo, Leitao Sun, Yuan Li, Harpreet Singh Wasan, Shanming Ruan · 2020 · The Lancet Oncology
  99. Reply to Colorectal cancer and COVID‐19: Do we need to raise awareness and vigilance?
    Qiuji Wu, Hongyan Zhang, Yahua Zhong, Melvin L.K. Chua, Conghua Xie · 2021 · Cancer
  100. Precast concrete wall-foundation connection. Development of a seismic dissipative connection
    Rui Marreiros · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)